Can Sarepta Keep Soaring?

[cnbc 3000119969]

Mad Money host Jim Cramer says don’t chase stocks, especially when they have moved as much as Sarepta has today. Chris Garabedian, Sarepta Therapeutics president

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply